X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-15 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $57.70 | -6,500 | 76,777 | -8% | -$375,050 | ||||||
2024-11-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $61.36 | -250 | 56,238 | 0% | -$15,340 | ||||||
2024-10-14 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $57.19 | -250 | 56,488 | 0% | -$14,298 | ||||||
2024-09-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $56.82 | -250 | 56,738 | 0% | -$14,205 | ||||||
2024-08-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $59.62 | -250 | 56,988 | 0% | -$14,905 | ||||||
2024-07-18 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $62.00 | -2,743 | 706,272 | 0% | -$170,066 | ||||||
| M | 2024-07-15 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $63.73 | -47,257 | 709,015 | -6% | -$3,011,592 | |||||
2024-07-12 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $64.91 | -250 | 58,981 | 0% | -$16,228 | ||||||
2024-07-01 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $63.44 | -20,000 | 242,905 | -8% | -$1,268,800 | ||||||
2024-06-21 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $58.90 | -20,000 | 756,272 | -3% | -$1,178,000 | ||||||
| M | 2024-06-17 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $60.59 | -30,000 | 776,272 | -4% | -$1,817,663 | |||||
2024-06-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $63.80 | -250 | 59,231 | 0% | -$15,950 | ||||||
2024-06-05 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale | $67.00 | -2,985 | 77,227 | -4% | -$199,995 | ||||||
2024-06-04 | ANIP | Carey Stephen P. | SVP, CFO | S - Sale | $63.58 | -5,000 | 161,968 | -3% | -$317,900 | ||||||
2024-06-03 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $64.41 | -20,000 | 262,905 | -7% | -$1,288,200 | ||||||
2024-05-21 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $61.61 | -2,000 | 83,277 | -2% | -$123,220 | ||||||
2024-05-20 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $61.81 | -12,855 | 806,272 | -2% | -$794,568 | ||||||
| M | 2024-05-15 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $64.37 | -37,145 | 819,127 | -4% | -$2,391,121 | |||||
2024-05-16 | ANIP | Tannenbaum Renee P | Dir | S - Sale | $63.87 | -2,000 | 18,211 | -10% | -$127,740 | ||||||
2024-05-14 | ANIP | Lalwani Nikhil | Pres, CEO | S - Sale | $66.10 | -16,669 | 377,505 | -4% | -$1,101,821 | ||||||
2024-05-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $67.69 | -250 | 59,481 | 0% | -$16,923 | ||||||
2024-05-01 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $66.62 | -20,000 | 282,905 | -7% | -$1,332,400 | ||||||
| M | 2024-04-18 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $65.10 | -27,232 | 856,272 | -3% | -$1,772,729 | |||||
| M | 2024-04-15 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $65.91 | -22,768 | 883,504 | -3% | -$1,500,589 | |||||
2024-04-12 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $67.79 | -250 | 59,731 | 0% | -$16,948 | ||||||
2024-04-01 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $67.25 | -20,000 | 302,905 | -6% | -$1,345,000 | ||||||
2024-03-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $66.54 | -250 | 59,981 | 0% | -$16,635 | ||||||
2024-03-11 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $65.81 | -20,000 | 322,905 | -6% | -$1,316,200 | ||||||
2024-03-08 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $67.17 | -10,000 | 906,272 | -1% | -$671,700 | ||||||
2024-03-11 | ANIP | Carey Stephen P. | SVP, CFO | S - Sale | $65.55 | -7,787 | 177,712 | -4% | -$510,438 | ||||||
| M | 2024-03-06 | ANIP | Lalwani Nikhil | Pres, CEO | S - Sale | $66.10 | -45,257 | 411,629 | -10% | -$2,991,469 | |||||
2024-03-07 | ANIP | Marken James G. | SVP Ops, Prod Dev | S - Sale | $66.37 | -24,338 | 122,458 | -17% | -$1,615,313 | ||||||
| M | 2024-03-05 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $65.77 | -40,000 | 916,272 | -4% | -$2,630,864 | |||||
2024-03-05 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $66.00 | -5,000 | 87,387 | -5% | -$330,000 | ||||||
2024-03-04 | ANIP | Pera Antonio R | Dir | S - Sale | $65.20 | -7,000 | 26,627 | -21% | -$456,400 | ||||||
2024-02-13 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $56.04 | -250 | 36,799 | -1% | -$14,010 | ||||||
| M | 2024-01-19 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $56.17 | -25,216 | 935,027 | -3% | -$1,416,466 | |||||
| M | 2024-01-16 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $55.29 | -24,784 | 960,243 | -3% | -$1,370,305 | |||||
2024-01-12 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $56.43 | -250 | 37,049 | -1% | -$14,108 | ||||||
| M | 2023-12-15 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $52.55 | -50,000 | 985,027 | -5% | -$2,627,250 | |||||
2023-12-11 | ANIP | Cook Meredith | SVP, GC, SEC. | S - Sale | $49.21 | -250 | 37,299 | -1% | -$12,303 | ||||||
2023-11-17 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $51.00 | -13,000 | 1,035,027 | -1% | -$663,000 | ||||||
| AM | 2023-11-14 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $53.00 | -37,000 | 995,620 | -4% | -$1,961,148 | |||||
2023-11-15 | ANIP | Davis Krista | SVP, CHRO | S - Sale | $53.81 | -2,622 | 32,587 | -7% | -$141,090 | ||||||
| M | 2023-11-14 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $53.00 | -36,190 | 1,048,837 | -3% | -$1,918,080 | |||||
2023-11-10 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $52.47 | -3,000 | 63,607 | -5% | -$157,410 | ||||||
| M | 2023-10-17 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $57.75 | -25,000 | 1,085,027 | -2% | -$1,443,869 | |||||
| M | 2023-10-13 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $57.96 | -25,000 | 1,110,027 | -2% | -$1,449,036 | |||||
2023-10-02 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $56.48 | -20,000 | 322,173 | -6% | -$1,129,600 | ||||||
| M | 2023-09-15 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $61.81 | -50,000 | 1,135,027 | -4% | -$3,090,617 | |||||
2023-09-01 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $64.70 | -20,000 | 342,173 | -6% | -$1,294,000 | ||||||
| M | 2023-08-28 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $63.22 | -50,000 | 1,185,027 | -4% | -$3,160,750 | |||||
| D | 2023-08-23 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale+OE | $62.39 | -15,561 | 60,915 | -20% | -$970,851 | |||||
| D | 2023-08-23 | ANIP | Marken James G. | SVP Ops, Prod Dev | S - Sale+OE | $63.00 | -3,932 | 133,112 | -3% | -$247,716 | |||||
2023-08-16 | ANIP | Meridian Venture Partners II LP | 10% | S - Sale | $58.50 | -200,000 | 1,819,259 | -10% | -$11,700,000 | ||||||
| M | 2023-08-14 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $61.35 | -50,000 | 1,235,027 | -4% | -$3,067,450 | |||||
2023-08-14 | ANIP | Carey Stephen P. | SVP, CFO | S - Sale | $61.37 | -17,639 | 155,839 | -10% | -$1,082,505 | ||||||
2023-08-14 | ANIP | Pera Antonio R | Dir | S - Sale | $60.37 | -3,000 | 33,627 | -8% | -$181,110 | ||||||
| DM | 2023-08-11 | ANIP | Lalwani Nikhil | Pres, CEO | S - Sale+OE | $58.33 | -68,282 | 353,390 | -16% | -$3,982,548 | |||||
2023-08-01 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $51.06 | -20,000 | 362,173 | -5% | -$1,021,200 | ||||||
| M | 2023-07-19 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $52.02 | -23,469 | 1,285,027 | -2% | -$1,220,844 | |||||
| M | 2023-07-14 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $51.02 | -26,531 | 1,308,496 | -2% | -$1,353,599 | |||||
2023-07-03 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $53.43 | -20,000 | 382,173 | -5% | -$1,068,600 | ||||||
| AM | 2023-06-20 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $51.70 | -50,000 | 1,335,027 | -4% | -$2,584,912 | |||||
2023-06-22 | ANIP | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $51.32 | -20,000 | 402,173 | -5% | -$1,026,400 | ||||||
| M | 2023-06-20 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS | S - Sale | $51.75 | -40,000 | 1,345,027 | -3% | -$2,070,012 | |||||
2022-12-01 | ANIP | Meridian Venture Partners II LP | 10% | S - Sale | $38.50 | -200,000 | 2,019,259 | -9% | -$7,700,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |